Literature DB >> 7018484

Captopril-induced agranulocytosis in systemic sclerosis.

M A Watson, N J Radford, B P McGrath, G W Swinton, J W Agar.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7018484     DOI： 10.1111/j.1445-5994.1981.tb03744.x

Source DB:  PubMed          Journal:  Aust N Z J Med        ISSN： 0004-8291


× No keyword cloud information.
  4 in total

1.  Successful pregnancy with scleroderma renal disease and pulmonary hypertension in a patient using angiotensin converting enzyme inhibitors.

Authors:  B A Baethge; R E Wolf
Journal:  Ann Rheum Dis       Date:  1989-09       Impact factor: 19.103

Review 2.  Captopril. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure.

Authors:  R N Brogden; P A Todd; E M Sorkin
Journal:  Drugs       Date:  1988-11       Impact factor: 9.546

Review 3.  Adverse reactions with angiotensin converting enzyme (ACE) inhibitors.

Authors:  R DiBianco
Journal:  Med Toxicol       Date:  1986 Mar-Apr

Review 4.  Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure.

Authors:  J A Romankiewicz; R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1983-01       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.